Literature DB >> 19690890

Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping.

Caitrin W McDonough1, Meredith A Bostrom, Lingyi Lu, Pamela J Hicks, Carl D Langefeld, Jasmin Divers, Josyf C Mychaleckyj, Barry I Freedman, Donald W Bowden.   

Abstract

Genetic studies in Turkish, Native American, European American, and African American (AA) families have linked chromosome 18q21.1-23 to susceptibility for diabetes-associated nephropathy. In this study, we have carried out fine linkage mapping in the 18q region previously linked to diabetic nephropathy in AAs by genotyping both microsatellite and single nucleotide polymorphisms (SNPs) for linkage analysis in an expanded set of 223 AA families multiplexed for type 2 diabetes associated ESRD (T2DM-ESRD). Several approaches were used to evaluate evidence of linkage with the strongest evidence for linkage in ordered subset analysis with an earlier age of T2DM diagnosis compared to the remaining pedigrees (LOD 3.9 at 90.1 cM, ΔP = 0.0161, NPL P value = 0.00002). Overall, the maximum LODs and LOD-1 intervals vary in magnitude and location depending upon analysis. The linkage mapping was followed up by performing a dense SNP map, genotyping 2,814 SNPs in the refined LOD-1 region in 1,029 AA T2DM-ESRD cases and 1,027 AA controls. Of the top 25 most associated SNPs, 10 resided within genic regions. Two candidate genes stood out: NEDD4L and SERPINB7. SNP rs512099, located in intron 1 of NEDD4L, was associated under a dominant model of inheritance [P value = 0.0006; Odds ratio (95% Confidence Interval) OR (95% CI) = 0.70 (0.57-0.86)]. SNP rs1720843, located in intron 2 of SERPINB7, was associated under a recessive model of inheritance [P value = 0.0017; OR (95% CI) = 0.65 (0.50-0.85)]. Collectively, these results suggest that multiple genes in this region may influence diabetic nephropathy susceptibility in AAs.

Entities:  

Mesh:

Year:  2009        PMID: 19690890      PMCID: PMC2937163          DOI: 10.1007/s00439-009-0732-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  43 in total

1.  Statistical tests for detection of misspecified relationships by use of genome-screen data.

Authors:  M S McPeek; L Sun
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Ordered subset analysis in genetic linkage mapping of complex traits.

Authors:  Elizabeth R Hauser; Richard M Watanabe; William L Duren; Meredyth P Bass; Carl D Langefeld; Michael Boehnke
Journal:  Genet Epidemiol       Date:  2004-07       Impact factor: 2.135

3.  Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25.

Authors:  F L Scott; H J Eyre; M Lioumi; J Ragoussis; J A Irving; G A Sutherland; P I Bird
Journal:  Genomics       Date:  1999-12-15       Impact factor: 5.736

4.  Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23.

Authors:  Irfan Vardarli; Leslie J Baier; Robert L Hanson; Imren Akkoyun; Christine Fischer; Peter Rohmeiss; Ali Basci; Claus R Bartram; Fokko J Van Der Woude; Bart Janssen
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

Review 5.  Genetic mapping in human disease.

Authors:  David Altshuler; Mark J Daly; Eric S Lander
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

Review 6.  Genetics of kidney disease.

Authors:  Donald W Bowden
Journal:  Kidney Int Suppl       Date:  2003-02       Impact factor: 10.545

7.  The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulation.

Authors:  Shuichi Ohtomo; Masaomi Nangaku; Yuko Izuhara; Norio Yamada; Takashi Dan; Takefumi Mori; Sadayoshi Ito; Charles van Ypersele de Strihou; Toshio Miyata
Journal:  Kidney Int       Date:  2008-06-25       Impact factor: 10.612

8.  Megsin 2093T-2180C haplotype at the 3' untranslated region is associated with poor renal survival in Korean IgA nephropathy patients.

Authors:  C S Lim; S M Kim; Y K Oh; K W Joo; Y S Kim; J S Han; S Kim
Journal:  Clin Nephrol       Date:  2008-08       Impact factor: 0.975

9.  Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3' untranslated region of the Megsin gene.

Authors:  You-Ji Li; Yong Du; Cai-Xia Li; Hui Guo; Joseph C K Leung; Man F Lam; Niansheng Yang; Fengxian Huang; Yun Chen; Ji-Qian Fang; Patrick H Maxwell; Kar N Lai; Yiming Wang
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

10.  The Kruppel-like zinc-finger gene ZNF236 is alternatively spliced and excluded as susceptibility gene for diabetic nephropathy.

Authors:  Niels Halama; Annette Yard-Breedijk; Irfan Vardarli; Imren Akkoyun; Benito Yard; Bart Janssen; Fokko J van der Woude
Journal:  Genomics       Date:  2003-09       Impact factor: 5.736

View more
  10 in total

Review 1.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

2.  A genome-wide association study for diabetic nephropathy genes in African Americans.

Authors:  Caitrin W McDonough; Nicholette D Palmer; Pamela J Hicks; Bong H Roh; S Sandy An; Jessica N Cooke; Jessica M Hester; Maria R Wing; Meredith A Bostrom; Megan E Rudock; Joshua P Lewis; Matthew E Talbert; Rebecca A Blevins; Lingyi Lu; Maggie C Y Ng; Michele M Sale; Jasmin Divers; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

3.  A likelihood ratio-based Mann-Whitney approach finds novel replicable joint gene action for type 2 diabetes.

Authors:  Qing Lu; Changshuai Wei; Chengyin Ye; Ming Li; Robert C Elston
Journal:  Genet Epidemiol       Date:  2012-07-03       Impact factor: 2.135

4.  Whole-genome genetic diversity in a sample of Australians with deep Aboriginal ancestry.

Authors:  Brian P McEvoy; Joanne M Lind; Eric T Wang; Robert K Moyzis; Peter M Visscher; Sheila M van Holst Pellekaan; Alan N Wilton
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

5.  Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians.

Authors:  Harini A Chakkera; Robert L Hanson; Sayuko Kobes; Meredith P Millis; Robert G Nelson; William C Knowler; Johanna K Distefano
Journal:  Mol Genet Metab       Date:  2011-02-19       Impact factor: 4.797

Review 6.  Genetics of diabetes complications.

Authors:  Sami Alkayyali; Valeriya Lyssenko
Journal:  Mamm Genome       Date:  2014-08-29       Impact factor: 2.957

7.  Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications.

Authors:  Zhongwen Zhang; Xiaoyun Wu; Tian Cai; Weiyi Gao; Xiaojun Zhou; Junyu Zhao; Jinming Yao; Hongxia Shang; Jianjun Dong; Lin Liao
Journal:  Int J Environ Res Public Health       Date:  2015-07-14       Impact factor: 3.390

8.  Five linkage regions each harbor multiple type 2 diabetes genes in the African American subset of the GENNID Study.

Authors:  Sandra J Hasstedt; Heather M Highland; Steven C Elbein; Craig L Hanis; Swapan K Das
Journal:  J Hum Genet       Date:  2013-04-04       Impact factor: 3.172

9.  The short isoform of the ubiquitin ligase NEDD4L is a CREB target gene in hepatocytes.

Authors:  Jingqi Fu; Dmitry Akhmedov; Rebecca Berdeaux
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

10.  Intracellular adhesion molecule-1 K469E gene polymorphism and risk of diabetic microvascular complications: a meta-analysis.

Authors:  Xianghui Su; Xi Chen; Lei Liu; Xiangyun Chang; Xuefeng Yu; Kan Sun
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.